185 related articles for article (PubMed ID: 34781924)
1. The construction and analysis of ceRNA network and patterns of immune infiltration in lung adenocarcinoma.
Li J; Liu W; Dong X; Dai Y; Chen S; Zhao E; Liu Y; Bao H
BMC Cancer; 2021 Nov; 21(1):1228. PubMed ID: 34781924
[TBL] [Abstract][Full Text] [Related]
2. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of competitive endogenous RNA associated with immune infiltration in lung adenocarcinoma.
Chen W; Li W; Liu Z; Ma G; Deng Y; Li X; Wang Z; Zhou Q
Sci Rep; 2021 May; 11(1):11056. PubMed ID: 34040139
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis and Validation of Competing Endogenous RNA Network and Tumor-infiltrating Immune Cells in Lung Adenocarcinoma.
Liu Y; Wu Q; Li J; Jia W; Zhai X; Yu J; Zhu H
Comb Chem High Throughput Screen; 2022; 25(13):2240-2254. PubMed ID: 35331104
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
Pan Y; Sha Y; Wang H; Zhuang H; Ren X; Zhu X; Wei X
J Cancer Res Ther; 2020; 16(2):320-326. PubMed ID: 32474519
[TBL] [Abstract][Full Text] [Related]
6. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Nomogram Based on Circular RNA-Associated Competing Endogenous RNA Network for Patients with Lung Adenocarcinoma.
Li Y; Sun R; Li R; Chen Y; Du H
Oxid Med Cell Longev; 2021; 2021():9978206. PubMed ID: 34497684
[TBL] [Abstract][Full Text] [Related]
9. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
[TBL] [Abstract][Full Text] [Related]
10. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Tan J; Wang W; Song B; Song Y; Meng Z
Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
12. Construction of an immune-related lncRNA pairs model to predict prognosis and immune landscape of lung adenocarcinoma patients.
Liu J; Wu H; Gao Z; Lou M; Yuan K
Bioengineered; 2021 Dec; 12(1):4123-4135. PubMed ID: 34288805
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
14. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
Chen G; Dong Z; Wu D; Chen Y
J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
[TBL] [Abstract][Full Text] [Related]
15. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of an immune-associated signature in lung adenocarcinoma.
Wang Z; Chen X
Int Immunopharmacol; 2020 Nov; 88():106867. PubMed ID: 32799112
[TBL] [Abstract][Full Text] [Related]
18. Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis.
Hou J; Yao C
Biomed Res Int; 2021; 2021():8859996. PubMed ID: 33511215
[TBL] [Abstract][Full Text] [Related]
19. Machine learning-based immune prognostic model and ceRNA network construction for lung adenocarcinoma.
He X; Su Y; Liu P; Chen C; Chen C; Guan H; Lv X; Guo W
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7379-7392. PubMed ID: 36939925
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
